ConductScience.org, home

Paper38653243

Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.

Jhajj HS and 8 others. Cell Chem Biol, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors. Papers, record 38653243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38653243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.
PubMed
Journal
Cell Chem Biol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.68, provisional
iCite
Revised in PubMed
2026-09-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jhajj HSHarkamal S
2Schardt JSJohn S
3Khalasawi NNamir
4Yao ELEmily L
5Lwo TSTimon S
6Kwon NYNa-Young
7O'Meara RLRyen L
8Desai AAAlec A
9Tessier PMPeter M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EpitopesMajor topic
Humans
Animals
Receptors, Tumor Necrosis Factor
Tumor Necrosis Factor Receptor Superfamily, Member 9
Receptors, OX40
Antibodies
Single-Chain Antibodies
Mice

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
F32 GM137513NIGMS NIH HHSUnited StatesF32GM137513PubMed and NIHNIH RePORTER
R01 AG080016NIA NIH HHSUnited StatesR01AG080016PubMed and NIHNIH RePORTER
R35 GM136300NIGMS NIH HHSUnited StatesR35GM136300PubMed and NIHNIH RePORTER
RF1 AG059723NIA NIH HHSUnited StatesRF1AG059723PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of38168220Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily.https://conductscience.org/library/papers/38168220

Source PubMed

Download CSV of comments and corrections

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124953012Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies.Trends Immunol2014https://conductscience.org/library/papers/24953012PubMed
228653573The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.Immunotherapy2017https://conductscience.org/library/papers/28653573PubMed
328405505MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential.Oncoimmunology2017https://conductscience.org/library/papers/28405505PubMed
435140196An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35140196PubMed
534058562Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement.Biochem Biophys Res Commun2021https://conductscience.org/library/papers/34058562PubMed
625169849TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.Cytokine Growth Factor Rev2014https://conductscience.org/library/papers/25169849PubMed
733424853Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening.Front Immunol2020https://conductscience.org/library/papers/33424853PubMed
823980122Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies.J Exp Med2013https://conductscience.org/library/papers/23980122PubMed
932698317Monoclonal Antibodies in Cancer Therapy.Antibodies (Basel)2020https://conductscience.org/library/papers/32698317PubMed
1029183788Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.J Mol Biol2018https://conductscience.org/library/papers/29183788PubMed
1131573956An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors.Clin Cancer Res2019https://conductscience.org/library/papers/31573956PubMed
1225996440New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma.Sci Rep2015https://conductscience.org/library/papers/25996440PubMed
1327192570Targeting T Cell Co-receptors for Cancer Therapy.Immunity2016https://conductscience.org/library/papers/27192570PubMed
1434274536The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains.Mol Ther2021https://conductscience.org/library/papers/34274536PubMed
1526274600Advances in Antibody Design.Annu Rev Biomed Eng2015https://conductscience.org/library/papers/26274600PubMed
1631894001Development of therapeutic antibodies for the treatment of diseases.J Biomed Sci2020https://conductscience.org/library/papers/31894001PubMed
1736344331Unlocking the potential of agonist antibodies for treating cancer using antibody engineering.Trends Mol Med2023https://conductscience.org/library/papers/36344331PubMed
1812536217Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library.Nat Biotechnol2003https://conductscience.org/library/papers/12536217PubMed
1930917623Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology.Molecules2019https://conductscience.org/library/papers/30917623PubMed
2033082574Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2.Nat Chem Biol2021https://conductscience.org/library/papers/33082574PubMed

See all 44 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42547263Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias.J Immunother Cancer2026https://conductscience.org/library/papers/42547263PubMed
42218135A simple and broadly applicable nanobody-based approach to generate potent TNFR agonists.Cell Death Dis2026https://conductscience.org/library/papers/42218135PubMed
41561762OX40/OX40L: a new target for tumor immunotherapy and its clinical research progress.Front Oncol2025https://conductscience.org/library/papers/41561762PubMed
39673023The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds.BioDrugs2025https://conductscience.org/library/papers/39673023PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TNFRSF47293PubTator's text mininghttps://conductscience.org/library/genes/7293NCBI Gene
TNFRSF93604PubTator's text mininghttps://conductscience.org/library/genes/3604NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKPP358776–PP358779

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38653243

GET https://conductscience.org/api/papers/v1/38653243/references?page=2